Success Metrics

Active Trials
1(33%)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Other(1)

Detailed Status

Recruiting1
Not yet recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
N/A
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

recruiting133%
not_yet_recruiting133%
unknown133%

Recent Activity

1 active trials
Showing 3 of 3
recruitingnot_applicable

Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) for Inflammation and Depression Following SCI

NCT06493071
not_yet_recruitingnot_applicable

Ameliorating Effects and Mechanisms of TaVNS on Constipation in PD Patients.

NCT06623591
unknownnot_applicable

The Efficacy and Safety of Transcutaneous Auricular Vagus Nerve Stimulation for Anxiety in PD

NCT05950347

Clinical Trials (3)

Showing 3 of 3 trials
NCT06493071Not Applicable

Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) for Inflammation and Depression Following SCI

Recruiting
NCT06623591Not Applicable

Ameliorating Effects and Mechanisms of TaVNS on Constipation in PD Patients.

Not Yet Recruiting
NCT05950347Not Applicable

The Efficacy and Safety of Transcutaneous Auricular Vagus Nerve Stimulation for Anxiety in PD

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3